Dietary Supplement
Potential |
 |
The New England Journal of Medicine
Volume 347:2046-2056 December 19, 2002 Number 25 |
Herbal medicine is an increasingly
common form of alternative therapy in the United States. A
1997 survey estimated that 12.1 percent of adults in the United
States had used an herbal medicine in the previous 12 months
(as compared with 2.5 percent in 1990), resulting in out-of-pocket
payments of $5.1 billion.1 Among those who had used herbal
medicine, 15.1 percent had seen an alternative-medicine practitioner,
with a total of 10.5 million office visits, 19.8 percent of
which had been completely or partially covered by insurance.
In 2001, $17.8 billion was spent in the United States on dietary
supplements, $4.2 billion of it for herbs and other botanical
remedies.
Regulation
Most herbal products in the
United States are considered dietary supplements and thus
are not regulated as medicines and are not required to meet
the standards for drugs specified in the Federal Food, Drug,
and Cosmetic Act. The only requirement is that these preparations
meet the standards set forth in the 1994 Dietary Supplement
and Health Education Act (DSHEA). Herbal products may be produced
without the assurance of compliance standards for Good Manufacturing
Practice (although such standards are being developed), and
they are marketed without prior approval of their efficacy
and safety by the Food and Drug Administration (FDA). According
to the DSHEA, the manufacturer of an herbal preparation is
responsible for the truthfulness of claims made on the label
and must have evidence that the claims are supported, yet
the DSHEA neither provides a standard for the evidence needed
nor requires submission of the evidence to the FDA. Under
the DSHEA, the manufacturer is permitted to claim that the
product affects the structure or function of the body, as
long as there is no claim of effectiveness for the prevention
or treatment of a specific disease, and provided there is
a disclaimer informing the user that the FDA has not evaluated
the agent. Some of the claims on the labels of herbal products
suggest that they can be used to treat disease, and accompanying
materials, produced by persons other than the manufacturer,
that overtly promote such use may be available where the herbal
remedies are sold. According to the DSHEA, the manufacturer
is responsible for controlling quality and safety, but if
a concern about safety arises, the burden of proof lies not
with the manufacturer but with the FDA, which has to prove
that the product is unsafe.
in the title: "Recent
patterns of medication use in the ambulatory adult population
of the United States" in JAMA-JOURNAL OF THE AMERICAN MEDICAL
ASSOCIATION 287: (3) 337-344 JAN 16 2002, conclusions: Herbals/supplements
were taken by 14% of the population. Among prescription drug
users, 16% also took an herbal/supplement. In any given week,
most US adults take at least 1 medication, and many take multiple
agents. The substantial overlap between use of prescription
medications and herbals/supplements raises concern about unintended
interactions. Documentation of usage patterns can provide
a basis for improving the safety of medication use.
|